阿迪波尼克丁受体激动剂adipoRon减轻了因伊米基莫德诱导的小鼠牛皮
Geng Sun1, Hai-Qian Zhao1, Yuan-Yuan Huang1
1State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
International immunopharmacology
|April 4, 2025
概括
新型治疗药物AdipoRon通过减少炎症和角质细胞增殖显著降低了牛皮症状. 这项研究强调了AdipoR1激活是牛皮的有希望的新治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病.
- 阿迪波涅丁/阿迪波涅丁受体1 (AdipoR1) 信号传递可能会影响牛皮炎症.
- 作为阿迪波R1激动剂的阿迪波Ron在牛皮的治疗潜力仍然未被探索.
研究的目的:
- 为了研究adipoRon对牛皮的作用.
- 在牛皮病模型中探索adipoRon作用的潜在机制.
主要方法:
- 在牛皮患者数据 (GEO数据库) 中对阿迪波涅丁表达的分析.
- 在一种因米奎莫德诱导的牛皮小鼠模型中的验证.
- 评估adipoRon局部给药对皮肤病变和炎症标志物的影响.
主要成果:
- 在牛皮性皮肤病变中,阿迪波涅克的表达减少.
- 局部AdipoRon治疗改善了因Imiquimod引起的皮肤病变.
- 阿迪波减少了促炎性细胞因子 (IL-6,IL-17A,IL-23) 和M1巨细胞的透,同时增加了M2巨细胞.
- 阿迪波通过AMPK激活抑制了巨细胞炎症和角质细胞增殖.
结论:
- 阿迪波具有与牛皮相关的抗炎和抗增殖特性.
- 在小鼠模型中,AdipoRon治疗减弱了牛皮的反应.
- 用adipoRon激活AdipoR1信号传递为牛皮提供了一个潜在的新疗法途径.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
124
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
124
01:25Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K